These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1713944)

  • 1. Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin.
    Wilks JW; Scott PS; Vrba LK; Cocuzza JM
    Int J Radiat Biol; 1991; 60(1-2):73-7. PubMed ID: 1713944
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of angiogenesis by suramin.
    Gagliardi A; Hadd H; Collins DC
    Cancer Res; 1992 Sep; 52(18):5073-5. PubMed ID: 1381276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization.
    McNatt LG; Weimer L; Yanni J; Clark AF
    J Ocul Pharmacol Ther; 1999 Oct; 15(5):413-23. PubMed ID: 10530702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.
    Danesi R; Del Bianchi S; Soldani P; Campagni A; La Rocca RV; Myers CE; Paparelli A; Del Tacca M
    Br J Cancer; 1993 Nov; 68(5):932-8. PubMed ID: 7692920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.
    Crum R; Szabo S; Folkman J
    Science; 1985 Dec; 230(4732):1375-8. PubMed ID: 2416056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase.
    Chen NT; Corey EJ; Folkman J
    Lab Invest; 1988 Oct; 59(4):453-9. PubMed ID: 2459497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of angiogenesis by aurintricarboxylic acid.
    Gagliardi AR; Collins DC
    Anticancer Res; 1994; 14(2A):475-9. PubMed ID: 7517120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiostatic steroid with or without glucocorticoid activity on metastasis.
    Sakamoto N; Tanaka NG
    Invasion Metastasis; 1987; 7(4):208-16. PubMed ID: 2444551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution.
    Ingber DE; Madri JA; Folkman J
    Endocrinology; 1986 Oct; 119(4):1768-75. PubMed ID: 2428602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiogenesis through modulation of collagen metabolism.
    Ingber D; Folkman J
    Lab Invest; 1988 Jul; 59(1):44-51. PubMed ID: 2455830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity.
    Pesenti E; Sola F; Mongelli N; Grandi M; Spreafico F
    Br J Cancer; 1992 Aug; 66(2):367-72. PubMed ID: 1380282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of angiogenesis with synthetic heparin substitutes.
    Folkman J; Weisz PB; Joullié MM; Li WW; Ewing WR
    Science; 1989 Mar; 243(4897):1490-3. PubMed ID: 2467380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis.
    Bahramsoltani M; Plendl J
    APMIS; 2007 Jan; 115(1):30-46. PubMed ID: 17223849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of angiostatic steroids and beta-cyclodextrin tetradecasulfate on corneal neovascularization in the rat.
    Proia AD; Hirakata A; McInnes JS; Scroggs MW; Parikh I
    Exp Eye Res; 1993 Dec; 57(6):693-8. PubMed ID: 7512045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
    Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S
    Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis.
    Pepper MS; Vassalli JD; Wilks JW; Schweigerer L; Orci L; Montesano R
    J Cell Biochem; 1994 Aug; 55(4):419-34. PubMed ID: 7525617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiostatic activity and metabolism of cortisol in the chorioallantoic membrane (CAM) of the chick embryo.
    McNatt LG; Lane D; Clark AF
    J Steroid Biochem Mol Biol; 1992 Aug; 42(7):687-93. PubMed ID: 1380295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiostatic steroids. Method of discovery and mechanism of action.
    Folkman J; Ingber DE
    Ann Surg; 1987 Sep; 206(3):374-83. PubMed ID: 2443088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustine.
    Arrieta O; Guevara P; Reyes S; Ortiz A; Rembao D; Sotelo J
    Eur J Cancer; 1998 Dec; 34(13):2101-6. PubMed ID: 10070318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides.
    Maione TE; Gray GS; Petro J; Hunt AJ; Donner AL; Bauer SI; Carson HF; Sharpe RJ
    Science; 1990 Jan; 247(4938):77-9. PubMed ID: 1688470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.